IfPA’s Patient Access Policy Blog

Veterans Issues Dominate Headache Policy Event

Add migraine to the long list of battles faced by veterans of the United States Armed Services. In a Tuesday policy panel sponsored by The

Read More

Cystic Fibrosis Community Celebrates New Treatment Option

The cystic fibrosis community received news worth celebrating this week. The Food and Drug Administration approved a new drug that helps address the underlying cause

Read More

Aetna Debacle Deepens Skepticism about Coverage Decisions

Think an informed medical expert is making the coverage decisions at your health insurance company?  You might think again. In a story that’s sending ripples

Read More

New Gout Alliance Releases “Fast Facts”

Gout can be painful and debilitating – but also treatable, explains a new Fast Facts policy brief. A product of the newly formed Alliance for

Read More

Epilepsy Day Highlights Access Challenges for Patients

More than 3.4 million people in the United States live with epilepsy, a neurological disorder that can cause seizures and violent muscle spasms. This February

Read More

Is the Right to Try Act Right for Patients?

“Patients with terminal conditions should have access to experimental treatments that could potentially save their lives,” declared President Donald Trump in his first State of

Read More

Research Confirms Prior Authorization Burden for Heart Patients

Insurance red tape is wearing down doctors who prescribe advanced cardiovascular drugs – and that could be bad for patients. New research from the University

Read More

Mounting Lawsuits Pressure States to Treat Prisoners with Hepatitis C

Lawsuits are piling up against states that withhold hepatitis C cures from prisoners. In Missouri, a class action lawsuit is under appeal.  In Florida, a

Read More

Congress Considers Loosening Restrictions on Off-label Discussions

Health insurers may soon have more data to inform their decisions about which prescription drugs and medical devices they cover. The Pharmaceutical Information Exchange Act,

Read More

Patients’ Nasty Co-pay Surprise

Patients who rely upon co-pay coupons to afford their prescription drugs may be in for a nasty surprise in 2018. A new trend has more

Read More
Back to Top